Drug recall · August 12, 2020
VILEVEV MB Urinary Antispetic recall
Why: cGMP deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
VILEVEV MB Urinary Antispetic (81.0 mg methenamine, 40.8 mg sodium phosphate monobasic and 10.8 mg methylene blue, 0.12 mg hyoscyamine sulfate and 32.4 mg phenyl salicylate), Rx Only, 90 Tablets per Bottle, Manufactured for: Vilvet Pharmaceuticals, Inc., Chester Springs, PA 19425, NDC 71186-000-24.
- Lots / codes
LOT M823J18-1, M823J18-2, M823J18-3 EXP 09/20; LOT M823D19-1 EXP 04/21
- Quantity
- 1,716 bottles
- Company
- Vilvet Pharmaceuticals Inc., Chester Springs, PA
- Distribution
- Nationwide within the US
- Initiated
- July 24, 2020 · Voluntary: Firm initiated
- Classified
- August 6, 2020
- Reported
- August 12, 2020
- Ended
- January 21, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hyoscyamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.